##

Understanding

Types by Site

STS are divided into a number of subtypes according to their histology. Some of the main subtypes are summarised in Table 1. The most frequently occurring STS subtypes include liposarcoma, leiomyosarcoma, synovial sarcoma and malignant fibrous histiocytoma1,2. The different subtypes differ in their biological behaviour, their response to treatment, and their prognosis. The majority of STS subtypes, including fibrosarcoma, liposarcoma, leiomyosarcoma, pleomorphic and synovial sarcomas, show limited sensitivity to current systemic therapies and are generally incurable when diagnosed as advanced ormetastatic disease3.

Table 1. STS subtypes and their prevalence2,6
SiteHistological subtype (% of patients)
Fat Liposarcoma (15%)
Muscle Leiomyosarcoma (12%), rhabdomyosarcoma (5%), gastrointestinal stromal
tumours (GIST)
Perivascular Haemangiopericytoma (<1%)
Joints Synovial sarcoma (10%)
Fibrous Fibrosarcoma (3%),malignant fibrous histiocytoma (28%)
Nervous System Malignant schwannoma, neurofibrosarcoma, neurogenic sarcoma, primitive
neuroectodermal tumours (PNET) - neuroblastoma (6%), Ewing’s sarcoma (2%)
Blood or Lymph vessels Angiosarcoma (2%), Kaposi’s haemangioendothelioma (1%)

In contrast, other histologic types like small round cell tumours (SRCTs), including Ewing’s sarcoma, are sensitive to current chemotherapy and potentially curable.4,5.

References:
1. Clark MA, Fisher C et al. (2005) “Soft-tissue sarcomas in adults.” N Engl JMed 353(7): 701–11.
2. Coindre J-M, Terrier P et al. (2001) “Predictive value of grade formetastasis development in themain histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group.” Cancer 91(10): 1914–26.
3. Hartmann JT, Patel S. (2005) “Recent developments in salvage chemotherapy for patients with metastatic soft tissue sarcoma.” Drugs 65(2): 167–78.
4. Bertuzzi A, Castagna L et al. (2002) “High-dose chemotherapy in poor-prognosis adult small round-cell tumors: clinical and molecular results from a prospective study.” J Clin Oncol 20(8): 2181–88.
5. Kushner BH, LaQuaglia MP et al. (1996) “Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy.” J Clin Oncol 14(5): 1526–31.
6. Cormier JN, Pollock RE (2004). “Soft tissue sarcomas”. CA Cancer J Clin 54(2): 94-109.

Please Log in
Free registration to access disease diagnosis, patient management, physician tools.

Only registered users have access to this content.

Already Registered?

Email    Password   

Not a member?

Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students. 

Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major theraputic areas, disease management, and clinical tools.

As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!

REGISTER today it only takes a minute! and it's FREE

If you are not a healthcare professional please visit our patient site.

Having problems?

Use our forgotten password facility or email us at: contact@epgonline.org

Exit Log in